source
- Genentech shuts infectious disease research unit and lays off senior scientists in latest R&D cutsGenentech announced another round of layoffs affecting its early research and development group. The cuts included the closure of its infectious disease research unit and the departure of several…
- Camurus receives second complete response letter for acromegaly drug CAM2029; Teva announces workforce reductionsCamurus reported that the FDA issued a second complete response letter for its investigational acromegaly therapy CAM2029, citing issues related to a third‑party manufacturer. The agency’s concern…